Cantor Fitzgerald Predicts VRTX FY2026 Earnings
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Vertex Pharmaceuticals in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst C. Gould forecasts that the pharmaceutical company will post earnings of $18.36 per share for the year. Cantor Fitzgerald currently has a “Overweight” […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Vertex Pharmaceuticals in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst C. Gould forecasts that the pharmaceutical company will post earnings of $18.36 per share for the year. Cantor Fitzgerald currently has a “Overweight” […]
